46
Participants
Start Date
July 3, 2019
Primary Completion Date
December 31, 2027
Study Completion Date
December 31, 2027
Inclusion examinations
Pregnancy test, Visual acuity, ocular pressure, color retinophotography, OCT-SD (the Heidelberg SDOCT Spectralis, or the Cirrus HD-OCT, model 5000, Zeiss), OCT-angiography and fluorescein angiography and wide-field angiogram
Aflibercept Injection [Eylea]
Intravitreal injection of aflibercept at inclusion, M1, M2, M3 and M4. An additional injection may be planned for M5, on the decision of the clinician and on clinical arguments only.
SHAM injection
Intravitreal injection of SHAM at inclusion, M1, M2, M3 and M4. An additional injection may be planned for M5, on the decision of the clinician and on clinical arguments only.
Examinations during study (every month)
visual acuity, ocular pressure, OCT-SD, OCT-angiography and ocular fundus and a pregnancy test at M6
RECRUITING
CHU dijon Bourgogne, Dijon
Centre Hospitalier Universitaire Dijon
OTHER